RXRX · Recursion Pharmaceuticals, Inc. · Fails to Deliver
$3.70
+0.12 (+3.35%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$1.98B
Shares
535.34M
Volume · Oct 23
19.08M
Avg daily vol (3M)
21.75M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-30 | 490,129 | $4.03 | $1,975,220 |
| 2026-09-29 | 627,425 | $3.70 | $2,321,473 |
| 2026-09-28 | 782,942 | $3.74 | $2,928,203 |
| 2026-09-25 | 470,126 | $3.89 | $1,828,790 |
| 2026-09-24 | 242,524 | $3.70 | $897,339 |
| 2026-09-23 | 73,931 | $4.05 | $299,421 |
| 2026-09-22 | 6,329 | $3.97 | $25,126 |
| 2026-09-21 | 2,726,286 | $3.83 | $10,441,675 |
| 2026-09-18 | 9,853 | $3.54 | $34,880 |
| 2026-09-17 | 1,996,570 | $3.19 | $6,369,058 |
| 2026-09-14 | 497,478 | $3.20 | $1,591,930 |
| 2026-09-10 | 400,138 | $3.22 | $1,288,444 |
| 2026-09-09 | 72,869 | $3.44 | $250,669 |
| 2026-09-08 | 1,917 | $3.63 | $6,959 |
| 2026-09-04 | 73 | $3.44 | $251 |
| 2026-09-03 | 247,538 | $3.38 | $836,678 |
| 2026-09-01 | 189,092 | $3.40 | $642,913 |
| 2026-08-31 | 345,423 | $3.34 | $1,153,713 |
| 2026-08-28 | 4,021 | $3.44 | $13,832 |
| 2026-08-26 | 302,205 | $3.56 | $1,075,850 |
| 2026-08-25 | 124,054 | $3.25 | $403,176 |
| 2026-08-24 | 135,512 | $3.50 | $474,292 |
| 2026-08-20 | 190,339 | $3.50 | $666,187 |
| 2026-08-19 | 315,374 | $3.09 | $974,506 |
| 2026-08-18 | 5,663 | $3.11 | $17,612 |
| 2026-08-17 | 107,727 | $3.16 | $340,417 |
| 2026-08-14 | 37,071 | $3.31 | $122,705 |
| 2026-08-12 | 4,705 | $3.35 | $15,762 |
| 2026-08-11 | 6 | $3.29 | $20 |
| 2026-08-10 | 7,517 | $3.22 | $24,205 |
| 2026-08-05 | 8,958 | $3.31 | $29,651 |
| 2026-08-04 | 54,030 | $3.18 | $171,815 |
| 2026-08-03 | 325 | $3.00 | $975 |
| 2026-07-30 | 14 | $2.97 | $42 |
| 2026-07-29 | 23 | $3.05 | $70 |
Showing 1–35 of 35 settlements
Key facts
CIK
1601830
CUSIP
75629V104
13F (30d)
51 filings
51 filers
Visit website
Investor relations